Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

131.73
BATS BZX Real-Time Price
As of 3:34pm ET
 -2.12 / -1.58%
Today’s Change
94.42
Today|||52-Week Range
135.18
+13.81%
Year-to-Date
Agios/Celgene's Leukemia Candidate Positive in Phase I/II
12:19pm / Zacks.com - Paid Partner Content
Biotech Stocks Finally Stage Breakthrough
Jun 22 / TheStreet.com - Paid Partner Content
Biotech stocks bounce as regulation fears ease
Jun 26 / FT.com - Paid Partner Content
The Market Advance Narrows
Jun 22 / TheStreet.com - Paid Partner Content
Epizyme Progressing Well on Two Lead Pipeline Candidates
Jun 26 / Zacks.com - Paid Partner Content
Cramer: This Is No Country for Old Value
Jun 21 / TheStreet.com - Paid Partner Content
On Not Talking About the 'Market'; Darth Vader, Meet Amazon: Jim Cramer's Best Blog
Jun 23 / TheStreet.com - Paid Partner Content
Celgene Heading for All-Time High
Jun 21 / TheStreet.com - Paid Partner Content
Dow 30 Stock Roundup: Boeing Bags Big Orders at Paris Air Show; Wal-Mart to Buy Bonob...
Jun 23 / Zacks.com - Paid Partner Content
Small Cancer Biotech Space in Focus, 3 Stocks Up 100% & More
Jun 21 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close133.85
Today’s open133.66
Day’s range131.69 - 133.81
Volume201,959
Average volume (3 months)3,898,745
Market cap$104.5B
Dividend yield--
Data as of 3:34pm ET, 06/27/2017

Growth & Valuation

Earnings growth (last year)+28.35%
Earnings growth (this year)+22.68%
Earnings growth (next 5 years)+20.02%
Revenue growth (last year)+22.70%
P/E ratio49.7
Price/Sales8.51
Price/Book15.79

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.13-0.31%
BMYBristol-Myers Squibb-0.99-1.74%
ABBVAbbVie-0.24-0.33%
LLYEli Lilly and Co-1.05-1.25%
Data as of 3:34pm ET, 06/27/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$1.78
Annual revenue (last year)$10.9B
Annual profit (last year)$2.0B
Net profit margin18.30%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President &
Chief Operating Officer
Scott Andrew Smith
Corporate headquarters
Summit, New Jersey

Forecasts